Morgan Stanley analyst Mike Cyprys maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $201 to $208.
Morgan Stanley raised CME Gr (NASDAQ:CME) price target to $208 Read Post »
Rosenblatt analyst Andrew Bond reiterates CME Gr (NASDAQ:CME) with a Sell and maintains $161 price target.
Rosenblatt maintained CME Gr (NASDAQ:CME) $161 price target Read Post »
Deutsche Bank analyst Brian Bedell raised its price target on CME Group Inc. (NASDAQ:CME) to $218 from $200 and maintained a buy rating on the stock. The analyst told investors that the company’s fourth-quarter results were “fairly solid,” with modest growth in revenue and interest income and a sharper increase in adjusted expenses. However, CME Group is demonstrating pricing power by increasing futures/options RPCs this year, which is actually a 4%-5% revenue increase. Combined with organic growth plans and transaction volume growth at a low median rate, Deutsche Bank believes the company’s EPS growth rate this year will be closer to 10 percent, up from just 3 percent previously.
CME Group Inc.(NASDAQ:CME) reported Q4 adjusted earnings of $1.92 per diluted share. Analysts polled by Capital IQ expected $1.88. Revenue for the quarter ended Dec. 31 was $1.21 billion. Analysts surveyed by Capital IQ expected $1.21 billion. The company said it declared a Q1 dividend of $1.10 per share, a 10% increase from the prior level of $1 per share.
CME Group Inc.(NASDAQ:CME)’s Q4 2022 Adjusted Earnings, Revenue Rise Read Post »
CME Group Inc.(NASDAQ:CME)Target Raised to $207.00/Share From $198.00 by Credit Suisse。
CME Group Inc.(NASDAQ:CME)Target Raised to $207.00/Share From $198.00 by Credit Suisse Read Post »
February 8, 2023 – CME Group Inc. (NASDAQ: CME) today reported financial results for the fourth quarter and full year of 2022. Q4 adjusted earnings of $1.92 per diluted share, Analysts polled by Capital IQ expected $1.88. Revenue for the quarter ended Dec. 31 was $1.21 billion, Analysts surveyed by Capital IQ expected $1.21 billion. The company reported revenue of $1.2 billion and operating income of $668 million for the fourth quarter of 2022. Net income was $638 million and diluted earnings per common share were $1.75. On an adjusted basis, net income was $698 million and diluted earnings per common share were $1.92. Total revenue for full-year 2022 was $5.0 billion and operating income was $3.0 billion. Net income was $2.7 billion and diluted earnings per common share were $7.40. On an adjusted basis, net income was $2.9 billion, and diluted earnings per common share were $7.97. Fourth-quarter 2022
CME Group Inc. (NASDAQ:CME) revenue grew 5.2% YoY to $1.2 billion in Q4 2022 Read Post »